RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor Oct 12, 2021
Insights into China’s Pharmaceutical Industry Trends from a 2,000-strong Industry Conference Sep 30, 2021 Life Science
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents Sep 16, 2021 Life Science
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies Jul 7, 2021 Life Science
Meet this innovative Telehealth company specializing in the diagnostic imaging and radiology field on Jun 10th! May 27, 2021 Life Science, Technology
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies May 19, 2021 Life Science, Technology
RepliCel Announces Appointment of Leading Dermatologist in Japan as Clinical Advisor May 17, 2021 Life Science, Technology
RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map May 11, 2021 Life Science, Technology
RepliCel Announces Appointment of Leading Sports Medicine Expert as Orthopedics Clinical Advisor (Japan) May 3, 2021 Life Science, Technology
RepliCel Closes Second Tranche of Strategic Investment Commitment Apr 29, 2021 Life Science, Technology
RepliCel Life Sciences Announces Intention to Pay Dividend on Preferred Shares Mar 31, 2021 Life Science, Technology
RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference Feb 18, 2021 Life Science, Technology
RepliCel Closes First Tranche of Strategic Investment Commitment Feb 10, 2021 Life Science, Technology
